Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

US Rx benefit bills: tax warning to seniors.
October 27, 2003

Minnesota seeks to be first US state to buy drugs from Canada, "perhap...
October 27, 2003

Indian biotech "set to grow 30% in 2003-4".
October 27, 2003

Philippines govt to boost generics sales through advertising, call cen...
October 27, 2003

Medarex licenses BioWa's Potelligent technology.
October 27, 2003

CYP1B1 gene altered in men with prostate cancer.
October 27, 2003

diaDexus signs deal with Human Genome Sciences.
October 27, 2003

Roche and deCODE identify genetic risk factors for MI.
October 27, 2003

Promising preclinical findings for MorphoSys' antibodies.
October 27, 2003

Epigenomics and Wellcome Trust Sanger Inst collab.
October 27, 2003

Roche beats forecasts with pharma sales up 13% in first 9 months.
October 27, 2003

Akzo Nobel pharma under pressure.
October 27, 2003

Eli Lilly's Strattera gains 16.3% of new Rxs in the USA.
October 27, 2003

Impotence drugs selling fast in South Korea.
October 27, 2003

IDEC wins patent ruling against Corixa, GSK and Coulter.
October 27, 2003

Cima reveals another takeover offer.
October 27, 2003

ZymoGenetics prices offering at $12.50/share.
October 27, 2003

Cubist prices offering at $10.50/share.
October 27, 2003

Global Fund: $623M in new grants to fight AIDS, TB, malaria.
October 27, 2003

"Few counterfeit drugs" in Belarus.
October 27, 2003

Lithuanian Rx imports down.
October 27, 2003

Estonian HIV warning.
October 27, 2003

Ukraine: nine-month pharma production.
October 27, 2003

Russian drug prices.
October 27, 2003

Losses flat at Northfield in fiscal1st quarter.
October 27, 2003

Halsey running out of cash after bleak 3rd qtr.
October 27, 2003

Higher M&A rates for UK pharma says report; R&D spending growth to las...
October 27, 2003

Salix announces deal with Korea's CKD.
October 27, 2003

Affymetrix and bioMerieux extend collaboration.
October 27, 2003

Novartis' sales in China up 9% at $121M in 2002.
October 27, 2003

China announces anti-monopoly law.
October 27, 2003

Altana opens new $47M research units.
October 27, 2003

Roche chief sees end of pharma growth.
October 27, 2003

Visudyne cleared in Japan for AMD.
October 27, 2003

TKT and Genzyme sign deal for I2S.
October 27, 2003

Schering AG licenses Ventavis US rights.
October 27, 2003

Aventis' Lantus appro in Japan for diabetes.
October 27, 2003

B-MS and Corgentech enter collaboration.
October 27, 2003

UK halts pharmacy inducement schemes.
October 27, 2003

UK "post-code Rxing" of Roche's Herceptin.
October 27, 2003

Latvia to introduce 5% VAT on medicines.
October 27, 2003

ICN to sell European manufacturing units.
October 27, 2003

Novartis' sales on track in third quarter; profits rise 7% as Diovan, ...
October 27, 2003

Forest's Namenda becomes first FDA-approved therapy for advanced AD.
October 27, 2003

Aventis' Ketek cleared in Japan for CARTIs.
October 27, 2003

French health spending growth slows.
October 27, 2003

German health funds prepare "health points" plans.
October 27, 2003

German panel doctors seek rights over visit charges.
October 27, 2003

Tokyo pharma stocks - week to Oct 20.
October 27, 2003

New Spanish pharma marketing guide.
October 27, 2003

UK plans to cut prices of four generic drugs.
October 27, 2003

Spanish drug sales for 2003 1st nine months.
October 27, 2003

French regional cancer center of excellence.
October 27, 2003

AstraZeneca strikes $100M Abgenix deal.
October 27, 2003

Genzyme swings to loss on acquisition costs.
October 27, 2003

Aventis Behring spearheads hemophilia education program.
October 27, 2003

Rasagiline reduces "off" time in PD.
October 27, 2003

Flamel gets US Ok for Basulin deal with B-MS.
October 27, 2003

GSK drops Flamel augmentin deal.
October 27, 2003

Pfizer India slams govt over new drug policy.
October 27, 2003

Guatemala/Mexico generic drug deal.
October 27, 2003

Egyptian pharma urges 30% price rise.
October 27, 2003

Adderall XR on track for US use in adults.
October 27, 2003

FDA rejects Pozen's lead migraine product.
October 27, 2003

Roche acquires rights to Ipsen's BIM 51077.
October 27, 2003

EU changes label for S-P's PegIntron.
October 27, 2003

Millennium narrows losses, revenues grow.
October 27, 2003

AstraZeneca profits likely down in 3rd qtr?
October 27, 2003

Lithuania's Fermentas to increase R&D.
October 27, 2003

Sales and profits down at Tecan in 3rd qtr.
October 27, 2003

Profits up at Amgen on strong sales growth.
October 27, 2003

2nd Mass city plans Canadian drug-buying.
October 27, 2003

McClellan warns of imports and Rx supply.
October 27, 2003

US insurer offering coupons for generics.
October 27, 2003

Eli Lilly limits supplies to Canadian pharmacies.
October 27, 2003

Page 1|2|3|4|5|6